Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 14 studies | 43% ± 17% | |
lung | 12 studies | 34% ± 18% | |
eye | 9 studies | 52% ± 14% | |
kidney | 6 studies | 36% ± 22% | |
pancreas | 4 studies | 38% ± 10% | |
intestine | 4 studies | 61% ± 7% | |
bone marrow | 4 studies | 40% ± 14% | |
liver | 4 studies | 39% ± 22% | |
lymph node | 4 studies | 38% ± 26% | |
peripheral blood | 3 studies | 30% ± 9% | |
placenta | 3 studies | 41% ± 10% | |
adrenal gland | 3 studies | 31% ± 15% | |
thymus | 3 studies | 71% ± 33% | |
breast | 3 studies | 24% ± 6% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 24779.74 | 2630 / 2642 | 100% | 190.15 | 705 / 705 |
ovary | 97% | 7747.33 | 174 / 180 | 98% | 112.87 | 420 / 430 |
uterus | 90% | 4834.72 | 153 / 170 | 99% | 243.20 | 456 / 459 |
intestine | 84% | 3329.75 | 812 / 966 | 93% | 83.01 | 489 / 527 |
skin | 68% | 5125.61 | 1237 / 1809 | 99% | 174.98 | 466 / 472 |
lung | 69% | 2574.64 | 396 / 578 | 92% | 98.23 | 1066 / 1155 |
breast | 63% | 2024.36 | 288 / 459 | 97% | 118.28 | 1089 / 1118 |
esophagus | 56% | 2462.51 | 807 / 1445 | 92% | 79.59 | 168 / 183 |
stomach | 42% | 1482.67 | 149 / 359 | 91% | 69.85 | 260 / 286 |
bladder | 29% | 702.81 | 6 / 21 | 97% | 144.06 | 491 / 504 |
kidney | 61% | 2268.76 | 54 / 89 | 59% | 25.55 | 532 / 901 |
thymus | 28% | 817.53 | 186 / 653 | 83% | 130.82 | 504 / 605 |
adrenal gland | 17% | 525.60 | 44 / 258 | 83% | 84.70 | 191 / 230 |
lymph node | 0% | 0 | 0 / 0 | 100% | 170.95 | 29 / 29 |
tonsil | 0% | 0 | 0 / 0 | 100% | 203.42 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 132.09 | 1 / 1 |
pancreas | 2% | 57.12 | 5 / 328 | 90% | 62.24 | 160 / 178 |
spleen | 83% | 3427.01 | 200 / 241 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 74% | 40.58 | 59 / 80 |
prostate | 25% | 695.37 | 61 / 245 | 43% | 18.98 | 217 / 502 |
liver | 4% | 176.13 | 10 / 226 | 53% | 31.72 | 215 / 406 |
adipose | 56% | 1876.08 | 675 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 41% | 1290.99 | 554 / 1335 | 0% | 0 | 0 / 0 |
peripheral blood | 30% | 4337.51 | 280 / 929 | 0% | 0 | 0 / 0 |
heart | 13% | 390.79 | 109 / 861 | 0% | 0 | 0 / 0 |
muscle | 2% | 62.95 | 19 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0035024 | Biological process | negative regulation of Rho protein signal transduction |
GO_0007019 | Biological process | microtubule depolymerization |
GO_1905098 | Biological process | negative regulation of guanyl-nucleotide exchange factor activity |
GO_0061436 | Biological process | establishment of skin barrier |
GO_0007052 | Biological process | mitotic spindle organization |
GO_0031175 | Biological process | neuron projection development |
GO_0031115 | Biological process | negative regulation of microtubule polymerization |
GO_0007165 | Biological process | signal transduction |
GO_0009615 | Biological process | response to virus |
GO_0031110 | Biological process | regulation of microtubule polymerization or depolymerization |
GO_0000281 | Biological process | mitotic cytokinesis |
GO_0007409 | Biological process | axonogenesis |
GO_0035556 | Biological process | intracellular signal transduction |
GO_0030334 | Biological process | regulation of cell migration |
GO_0070495 | Biological process | negative regulation of thrombin-activated receptor signaling pathway |
GO_0048012 | Biological process | hepatocyte growth factor receptor signaling pathway |
GO_0051497 | Biological process | negative regulation of stress fiber assembly |
GO_0005874 | Cellular component | microtubule |
GO_0016020 | Cellular component | membrane |
GO_0070062 | Cellular component | extracellular exosome |
GO_0043005 | Cellular component | neuron projection |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0015631 | Molecular function | tubulin binding |
GO_0005515 | Molecular function | protein binding |
Gene name | STMN1 |
Protein name | Stathmin (Leukemia-associated phosphoprotein p18) (Metablastin) (Oncoprotein 18) (Op18) (Phosphoprotein p19) (pp19) (Prosolin) (Protein Pr22) (pp17) Stathmin |
Synonyms | OP18 LAP18 C1orf215 |
Description | FUNCTION: Involved in the regulation of the microtubule (MT) filament system by destabilizing microtubules. Prevents assembly and promotes disassembly of microtubules. Phosphorylation at Ser-16 may be required for axon formation during neurogenesis. Involved in the control of the learned and innate fear (By similarity). . |
Accessions | ENST00000357865.6 [P16949-1] Q96CE4 ENST00000374291.5 [P16949-1] ENST00000455785.7 [P16949-1] B5BU83 P16949 ENST00000399728.5 [P16949-1] ENST00000426559.6 [P16949-2] ENST00000446334.1 A2A2D0 |